"Humoral immunity of BBIBP‐CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The mortality of coronavirus disease 2019 (COVID‐19) is high in transplant patients, and effective vaccination is aimed to reduce severe disease and mortality. Click to show full abstract

The mortality of coronavirus disease 2019 (COVID‐19) is high in transplant patients, and effective vaccination is aimed to reduce severe disease and mortality.

Keywords: immunity bbibp; corv sinopharm; vaccination; bbibp corv; humoral immunity; transplant

Journal Title: Transplant Infectious Disease
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended